Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Restructuring May Be Next After Drugs Center Loses More Than 1,000 People

Apr 04 2025

• By Derrick Gingery

HHS is considering plans to restructure the FDA and other agencies. (Shutterstock)

Related Content

US FDA Staff Cuts: Biopharma Industry Braces For Impact, But First Wants Clarity On Losses

Feb 19 2025

Drug Reviewers And Legal Staff Among Those Called Back to US FDA, But Why?

Feb 24 2025

US FDA Reviewers, Inspectors Not Eligible For HHS Buyouts

Mar 10 2025

Updated: US Likely To Lose Its First Approver Advantage After FDA Layoffs

Apr 01 2025

Are Bigger Ad Policy Changes Coming After US FDA’s Drug Promotion Office Hit Hard By Layoffs?

Apr 03 2025

Makary Pledges To Uphold Gold Standard Science, But First Address Confuses Some US FDA Staff

Apr 03 2025

Additional Topics

FDA Politics Political parties Politicians Regulation Regulatory bodies Consumer OTC Drugs Dietary Supplements Cosmetics United States International

More from Leadership

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window